Literature DB >> 18478590

Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C.

Julia Rankin1, Michaela Auer-Grumbach, Warwick Bagg, Kevin Colclough, Thuy Duong Nguyen, Jane Fenton-May, Andrew Hattersley, Judith Hudson, Philip Jardine, Dragana Josifova, Cheryl Longman, Robert McWilliam, Katharine Owen, Mark Walker, Manfred Wehnert, Sian Ellard.   

Abstract

Mutations in the LMNA gene result in diverse phenotypes including Emery Dreifuss muscular dystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy with conduction system disease, Dunnigan type familial partial lipodystrophy, mandibulo acral dysplasia, Hutchinson Gilford progeria syndrome, restrictive dermopathy and autosomal recessive Charcot Marie Tooth type 2. The c.1930C > T (R644C) missense mutation has previously been reported in eight unrelated patients with variable features including left ventricular hypertrophy, limb girdle muscle weakness, dilated cardiomyopathy and atypical progeria. Here we report on the details of nine additional patients in eight families with this mutation. Patients 1 and 2 presented with lipodystrophy and insulin resistance, Patient 1 having in addition focal segmental glomerulosclerosis. Patient 3 presented with motor neuropathy, Patient 4 with arthrogryposis and dilated cardiomyopathy with left ventricular non-compaction, Patient 5 with severe scoliosis and contractures, Patient 6 with limb girdle weakness and Patient 7 with hepatic steatosis and insulin resistance. Patients 8 and 9 are brothers with proximal weakness and contractures. Nonpenetrance was observed frequently in first degree relatives. This report provides further evidence of the extreme phenotypic diversity and low penetrance associated with the R644C mutation. Possible explanations for these observations are discussed. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18478590     DOI: 10.1002/ajmg.a.32331

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  37 in total

Review 1.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

2.  Modifier locus of the skeletal muscle involvement in Emery-Dreifuss muscular dystrophy.

Authors:  B Granger; L Gueneau; V Drouin-Garraud; V Pedergnana; F Gagnon; R Ben Yaou; S Tezenas du Montcel; G Bonne
Journal:  Hum Genet       Date:  2010-11-10       Impact factor: 4.132

3.  Left ventricular noncompaction in a family with lamin A/C gene mutation.

Authors:  John J Parent; Jeffrey A Towbin; John L Jefferies
Journal:  Tex Heart Inst J       Date:  2015-02-01

Review 4.  Arthrogryposis: a review and update.

Authors:  Michael Bamshad; Ann E Van Heest; David Pleasure
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

5.  Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy.

Authors:  Jincy Winston; Laura Duerden; Matthew Mort; Ian M Frayling; Mark T Rogers; Meena Upadhyaya
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

6.  Lamin A/C mutations do not cause left ventricular hypertrabeculation/noncompaction.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Tex Heart Inst J       Date:  2015-06-01

7.  The Drosophila nuclear lamina protein otefin is required for germline stem cell survival.

Authors:  Lacy J Barton; Belinda S Pinto; Lori L Wallrath; Pamela K Geyer
Journal:  Dev Cell       Date:  2013-06-24       Impact factor: 12.270

8.  Clinical Utility Gene Card for: Familial partial lipodystrophy.

Authors:  Isabelle Jéru; Camille Vatier; David Araujo-Vilar; Corinne Vigouroux; Olivier Lascols
Journal:  Eur J Hum Genet       Date:  2016-08-03       Impact factor: 4.246

Review 9.  Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction.

Authors:  Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2009-01-29       Impact factor: 1.655

10.  Cytoplasmic localization of PML particles in laminopathies.

Authors:  F Houben; W H De Vos; I P C Krapels; M Coorens; G J J Kierkels; M A F Kamps; V L R M Verstraeten; C L M Marcelis; A van den Wijngaard; F C S Ramaekers; J L V Broers
Journal:  Histochem Cell Biol       Date:  2012-08-25       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.